产品详情
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.66 mL | 103.31 mL | 206.63 mL |
0.5 mM | 4.13 mL | 20.66 mL | 41.33 mL |
1 mM | 2.07 mL | 10.33 mL | 20.66 mL |
5 mM | 0.41 mL | 2.07 mL | 4.13 mL |
*The above data is based on the productmolecular weight 483.96. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A16035 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 483.96 |
Formula | C26H27ClFN3O3 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 309913-42-6 |
Synonyms | SX011, SX-011 |
SMILES | ClC1=C(C=C2C(N(C)C=C2C(C(N(C)C)=O)=O)=C1)C(N3CCC(CC(C=C4)=CC=C4F)CC3)=O |
产品标签
Product Questions
Product Questions
Talmapimod (SCIO-469)
Talmapimod (SCIO-469)是一种具有ATP竞争性的选择性p38抑制剂(体外p38α的IC50 = 9 nM)。
DBM 1285 dihydrochloride
DBM 1285 dihydrochloride是p38 MAPK抑制剂。在巨噬细胞和体内抑制p38磷酸化和LPS诱导的TNF-α产生。
Pexmetinib (ARRY-614)
Pexmetinib (ARRY-614)是通过双重抑制p38促分裂原活化蛋白激酶(MAPK)和Tie2/Tek受体酪氨酸激酶,其在HEK-293细胞…
SB 239063
SB 239063是一种强效选择性p38 MAPKα/β抑制剂(p38α的IC50=44 nM)。SB 239063对ERK, JNK1和其他激酶的选择性超过220倍…
TRC 051384
TRC 051384,属于取代的2-丙烯-1-酮类,是热休克蛋白70(HSP70)的有效诱导剂。HSP70的诱导是应激细胞的自然…
LY2228820 (Ralimetinib)
LY2228820 (Ralimetinib)是一种新型强效p38MAPK抑制剂,具有强效抗炎活性。
Dilmapimod
Dilmapimod是p38 MAPK抑制剂。